According to a recent study, induction therapy with ixekizumab in patients with moderate-to-severe plaque psoriasis may offer faster symptom relief but shows lower long-term drug survival.
Recent study suggests plant-rich diets with low saturated fats may be associated with reduced PsO severity
According to a recent study, healthier eating patterns may be linked to psoriasis severity.
Oral roflumilast efficacious in treating moderate-to-severe plaque PsO
According to a recent real-world study, oral roflumilast was efficacious in reducing disease severity in moderate-to-severe plaque psoriasis.
Inflammation may be linked to stomach problems in psoriasis patients
According to a recent study, inflammation in psoriasis patients may be tied to stomach problems.
New study links stress and psoriasis relapse
According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).
Home-based narrowband UV-B phototherapy for PsO as effective as office-based treatment
According to a recent study, home-based narrowband UV-B phototherapy for plaque and guttate psoriasis is as effective as office-based treatments.
Veterans are more at risk for psoriasis, skin cancer
According to a recent study, U.S. veterans are more likely to have a history of skin cancer, melanoma, and psoriasis when compared to non-veterans.
Extended guselkumab dosing effective for PsO super responders
According to a recent study, extending the dosing interval of guselkumab from eight weeks to sixteen weeks is non-inferior for treating moderate-to-severe psoriasis in super-responders.
PsO disease severity linked to missed work days
According to a recent study, patients with moderate-to-severe psoriasis are more than twice as likely to take a half-day off work than those with mild psoriasis.
Study suggests significant autoimmune disease prevalence in PsO patients
According to a recent study, there is a significant autoimmune disease prevalence in psoriasis patients.
